Drug use profile in a Nigerian City Hospital

Pharmacoepidemiology and Drug Safety

Volumn 6, Issue 5, 1997, Pages 319-324

  Isah, A O ^a   Ohaju Obodo, J ^a   Isah, E C ^a   Ozemoya, O ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Drug use; Hospital; Nigeria; WHO indicators

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIPYRETIC ANALGESIC AGENT; CEPHALOSPORIN; CHLOROQUINE; COTRIMOXAZOLE; DIPYRONE; ERYTHROMYCIN; ESSENTIAL DRUG; FANSIDAR; HALOFANTRINE; MINOCYCLINE; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUININE; TETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DRUG USE; FEVER; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALARIA; NIGERIA; ORAL DRUG ADMINISTRATION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 0030807846     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U     Document Type: Article

References (14)

1. Isenalumhe, A. E. and Oviawe, O. Polypharmacy: its cost burden and barrier to medical care in a drug orientated health care system. International Journal of Health Services 1988; 18: 335-342.
2. Laing, R. O. Rational drug use: an unsolved problem. Tropical Doctor 1990; 20: 101-103.
3. Mabadeje, A. F. B., Akintowa, A. A. and Ashorobi, R. A. The value and effects of implementing an essential drugs list in the Lagos University Teaching Hospital. Clinical Pharmacology and Therapeutics 1991; 50: 121-124.
4. Oviawe, O., Okonokhua, L. and Isenalumhe, A. Prescriber performance in a paediatric general practice clinic of a University teaching hospital. West African Journal of Medicine 1989; 8: 130-134.
5. Drug Action Programme - World Health Organisation. Indicator Manual - How to Investigate Drug Use in Health Facilities. Selected Drug Use Indicators. WHO/DAP/92.1. WHO, Geneva, Switzerland, 1993.
6. Hogerzeil, H. V., Buno, D., Ross-Degnan, D. et al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342: 1408-1410.
7. Tomson, G. Pilot study of drug use indicators in Sweden. INRUD News 1992; 3: 3.
8. Hogerzeil, H. V., Walker, G. J. A., Sallami, A. O. and Fernando, G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1989; 1: 141-142.
9. Reeler, A. V. and Hematorn, C. Injection Practices in the Third World. A Case Study of Thailand. Action programme on essential drugs, World Health Organisation, Geneva, 1994.
10. Soumerai, S. B. and Avorn, J. Principles of educational outreach (Academic Detailing) to improve clinical decision making. Journal of the American Medical Association 1990; 263: 549-556.
11. Obaseiki-Ebor, E. E., Akerele, J. O. and Ebea, P. O. A survey of antibiotic outpatient prescribing and antibiotic self medication. Journal of Antimicrobial Chemotherapy 1987; 20: 759-763.
12. Smith, A. J., Aronson, J. K. and Thomas, M. Antibiotics policies in the developing world. European Journal of Clinical Pharmacology 1991; 41: 85-87.
13. Levy, S. B. Antibiotic availability and use: consequences to man and his environment. Journal of Clinical Epidemiology 1991; 44 (Suppl. II): 83-87S.
14. Adikwu, M. U. and Osondu, B. O. Four years of Essential Drugs Lists in Nigeria. Social Science and Medicine 1991; 33: 1005-1010.